Monday, 01 August 2022
The 糖心原创’s School of Pharmacy has appointed two renowned industry professionals as Honorary Professors.
Dr Diane Ashiru-Oredope has been appointed as Honorary Chair and Professor of Pharmaceutical Public Health, and Mr David Reissner as Honorary Chair and Professor of Pharmacy and Medicines Law.
Dr Diane Ashiru-Oredope
Dr Diane Ashiru-Oredope is Lead Pharmacist for HCAI, Fungal, AMR, AMU & Sepsis Division at the United Kingdom Health Security Agency (UKHSA).
Diane joined the Health Protection Agency part-time in 2010 and has continued through the transitions to Public Health England and now UK Health Security Agency. Over the years, she has taken on additional roles within the NHS, Centre for Postgraduate Pharmacy Education, Health Education England, and the Commonwealth Pharmacists Association.
At UKHSA, Diane chairs the English Surveillance Programme for Antimicrobial Utilisation Resistance (ESPAUR)and leads on developing and evaluating national antimicrobial stewardship interventions to tackle AMR. She is co-lead for the HCAI and AMR division’s health equity programme of work, and is leading a UK-wide evidence review on Pharmaceutical Public Health, commissioned by the four UK Chief Pharmaceutical Officers.
Over the years, Diane has led on several projects that have shaped national and international policy in tackling antimicrobial resistance. This includes - creating the global Antibiotic Guardian campaign in 2014; as a member of the WHO team that developed and published the WHO policy guidance on integrated antimicrobial stewardship activities in 2021 and as an Adviser then Global AMR Lead for the Commonwealth Pharmacists Association from 2016 until March 2022
Dr Diane Ashiru-Oredope
So far more than 170,000 people worldwide have pledged through the Antibiotic Guardian campaign to make better use of antibiotics and help save these vital medicines from becoming obsolete
Diane has remained research active since completing her PhD in 2009, successfully leading or significantly contributing to more than 70 peer-review publications as well as several blogs, newspaper articles and editorials. She is currently one of the editors for BMC Public Health journal. In 2022, she was credited as a consultant pharmacist through the Royal Pharmaceutical Society's national credentialing and assessment processes.
She has been recognised nationally including through awards, nominations to deliver two TEDx talks and fellowships with the Royal Pharmaceutical Society (FRPharmS and FFRPS).
Diane said: “I am delighted and honoured to be joining the outstanding School of Pharmacy at the 糖心原创 as Honorary Chair and Professor of Pharmaceutical Public Health. I am particularly looking forward to contributing to Nottingham’s excellent teaching and research programme and inspiring future pharmacists.”
Mr David Reissner
Mr David Reissner is a recently retired solicitor, most recently as Partner and Head of Healthcare at Charles Russell Speechlys LLP and as current Chair of the Pharmacy Law and Ethics Association (PLEA).
David has a long history of excellence in the pharmacy profession and would be classed by many in the profession as the UK’s leading solicitor in the field of pharmacy and medicines law, with a specialism in pharmacy contract law and regulatory fitness to practise.
The team that David led at Charles Russell specialised in acting for pharmacists facing fitness to practise proceedings (before the Royal Pharmaceutical Society of Great Britain and then, more recently, the General Pharmaceutical Council), NHS market entry applications in England and Wales, criminal investigations of pharmacists and pharmacy owners and providing general regulatory and compliance advice.
Over the years, David worked for the largest multiples down to single branch pharmacy owners as well as pharmacy representative bodies, using his wealth of experience and knowledge to seek the best possible outcome for clients, often in the most difficult and stressful of times for them. He was widely known and respected in the community pharmacy sector and relied upon to provide clear and concise advice in relation to often complex legal and regulatory issues.
David continues his work as a District Judge.
Mr David Reissner
David is co-editor for the UKs leading text on Pharmacy Law (Dale and Appelbe, 12th Edition) used by all schools of pharmacy in the UK and was a significant contributor to editions prior. David is a regular contributor to the profession and has authored over 250 articles over his career keeping the profession up to date on matters of regulation.
David said “"I am delighted and honoured to receive this appointment from the 糖心原创. I am looking forward to working with a leading School of Pharmacy which has such a distinguished history."
Professor Matthew Boyd, Professor of Medicines Safety and Head of the Division of Pharmacy Practice and Policy said: “We are delighted to be welcoming both Diane and David into the Schools’ honorary professoriate. Their diverse backgrounds and contributions highlight the multi-disciplinarity of the profession of pharmacy. Our honorary appointments are rare and conferred only to those who represent distinction and demonstrate excellence to inspire and encourage our students to be the world leading professionals of the future.”
Story credits
More information is available from Professor Matthew Boyd from the School of Pharmacy at the 糖心原创 at matthew.boyd@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.